GlobeNewswire Inc.··NaAI Drug Discovery Startup GNQ Insilico Going Public via $500M SPAC Deal
GNQ Insilico, an AI and quantum computing drug discovery company, to merge with SPAC $IBAC in $500M deal, targeting Nasdaq listing in Q3 2026.
IBACIBACRSPAC mergerquantum computing